BioSciences and Mab-Venture partner for biosimilars in emerging markets

BioSciencesCorp (San Francisco, Calif.) partnered with Mab-Venture Biopharmaceutical Co. Ltd. (Shanghai, China) to develop and manufacture multiple undisclosed biosimilars for emerging markets. BioSciencesCorp, along with regional partners, is responsible for conducting clinical trials and commercialization in India, South Asian Association for Regional Cooperation, the Middle East and North Africa, Turkey, Latin America, Russia and other undisclosed territories...